Catalent Inc (CTLT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
63.48 unch (unch) 12/17/24 [NYSE]
N/A x N/A N/A x N/A
Post-market 63.48 unch (unch) -
for Tue, Dec 17th, 2024
Results
download Want to compare other data? Select Fields| Symbol | CTLT | UTHR | NBIX | ||
| Company | Catalent Inc | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 63.49 | 317.10 | 107.79 | ||
| High | 63.50 | 319.40 | 107.80 | ||
| Low | 63.44 | 293.03 | 105.89 | ||
| Last | 63.48 | 296.70 | 106.75 | ||
| Change | unch | -4.06 | -0.49 | ||
| % Change | unch | -1.35% | -0.46% | ||
| Volume | 13,882,000 | 306,639 | 340,199 | ||
| 20-Day Average Volume | 3,342,940 | 439,821 | 1,749,462 | ||
| Previous Close | 63.48 | 300.76 | 107.24 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 61.63 | 291.45 | 99.80 | ||
| 20-Day Raw Stochastic | 99.61% | 58.39% | 93.72% | ||
| 20-Day Relative Strength | 70.63% | 46.38% | 50.35% | ||
| Weighted Alpha | +37.93 | +0.64 | -26.77 | ||
| Today's Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 8% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.99% since 12/10/24 | +1.41% since 04/23/25 | +3.72% since 04/23/25 | ||
| Low | 62.22 on 12/11/24 | 286.93 on 04/25/25 | 101.15 on 04/24/25 | ||
| High | 63.50 on 12/17/24 | 319.40 on 04/30/25 | 108.59 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +7.41% since 11/15/24 | -3.06% since 03/28/25 | -5.39% since 03/28/25 | ||
| Low | 58.39 on 11/19/24 | 266.98 on 04/09/25 | 84.23 on 04/09/25 | ||
| High | 63.50 on 12/17/24 | 319.40 on 04/30/25 | 112.60 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +5.19% since 09/17/24 | -15.53% since 01/30/25 | -30.16% since 01/30/25 | ||
| Low | 58.29 on 11/05/24 | 266.98 on 04/09/25 | 84.23 on 04/09/25 | ||
| High | 63.50 on 12/17/24 | 383.51 on 02/19/25 | 154.35 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | +14.98% since 06/17/24 | -17.66% since 10/30/24 | -13.89% since 10/30/24 | ||
| Low | 54.55 on 06/20/24 | 266.98 on 04/09/25 | 84.23 on 04/09/25 | ||
| High | 63.50 on 12/17/24 | 417.82 on 11/08/24 | 154.61 on 01/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,522,381 | 13,507,731 | 10,610,111 | ||
| Shares Outstanding, K | 181,512 | 44,912 | 98,938 | ||
| Annual Sales | 4,381,000,000 | 2,877,400,000 | 2,355,300,000 | ||
| Annual Net Income | -1,043,000,000 | 1,195,100,000 | 341,300,000 | ||
| Last Quarter Sales | 1,023,000,000 | 735,900,000 | 627,700,000 | ||
| Last Quarter Net Income | -129,000,000 | 301,300,000 | 103,100,000 | ||
| 60-Month Beta | 1.15 | 0.63 | 0.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/05/24 | 6.19 on 02/26/25 | 1.00 on 02/06/25 | ||
| Latest Earnings Date | 11/20/24 | 04/30/25 | 05/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.07 | 32.36 | ||